Clinical approach to inborn errors of metabolism presenting in the newborn period

C J Ellaway1, B Wilcken, J Christodoulou

  • 1Western Sydney Genetics Program, Royal Alexandra Hospital for Children and Department of Paediatrics and Child Health, University of Sydney, Sydney, New South Wales, Australia.

Insights

Inborn errors of metabolism (IEM) are rare but serious conditions. Early recognition and prompt management by pediatricians and neonatologists are crucial for improving outcomes in affected infants.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Neonatology

Background:

  • Inborn errors of metabolism (IEM) are a group of rare genetic disorders.
  • Collectively, IEM contribute significantly to pediatric morbidity and mortality.
  • Over 400 distinct IEM have been identified, presenting diverse biochemical challenges.

Purpose of the Study:

  • To provide a practical guide for recognizing and investigating neonates with potential IEM.
  • To outline guidelines for the initial management and stabilization of high-risk infants.
  • To emphasize the critical role of pediatricians and neonatologists in early diagnosis.

Main Methods:

  • Review of current literature and clinical guidelines.
  • Focus on practical diagnostic and management strategies for neonates.
  • Emphasis on collaborative care with specialized metabolic units.

Main Results:

  • Advances in diagnosis and treatment have improved prognoses for many IEM.
  • Rapid diagnosis is essential to prevent mortality and neurological damage.
  • Guidelines are provided for timely intervention in at-risk neonates.

Conclusions:

  • Early identification and management of IEM in neonates are critical.
  • Collaboration between frontline clinicians and specialized units improves patient outcomes.
  • This review offers a practical framework for managing suspected IEM in infants.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Introduction to Metabolism01:30

Introduction to Metabolism

Metabolism encompasses all biochemical reactions in a living organism, facilitating both the breakdown and synthesis of biomolecules. These metabolic processes are categorized into catabolic and anabolic pathways, which operate in a coordinated manner to ensure energy balance and cellular function.Catabolic Pathways and Energy ReleaseCatabolic pathways involve the breakdown of complex macromolecules such as carbohydrates, lipids, and proteins into smaller structures like monosaccharides, fatty...
The Nativist Approach01:21

The Nativist Approach

The nativist approach to infant cognitive development proposes that infants are born with inherent knowledge structures that allow them to interpret the world almost immediately. This perspective contrasts with earlier developmental theories, such as those proposed by Jean Piaget, which emphasized a more gradual acquisition of cognitive abilities through interaction with the environment. One key concept in this approach is object permanence — the understanding that objects continue to exist...